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 Abstract 
 This report presents the case of a middle-aged 
Torres Strait Islander male with HIV who contracted 
Plasmodium vivax malaria in Papua New Guinea. 
His presentation included clinical and radiological 
features of pneumonia and he required inpatient 
treatment for 13 days. This study reviews the litera-
ture concerning co-infection with HIV and malaria, 
which is an uncommon combination in Australia, 
discusses the public health risks posed by patients 
with malaria in the Torres Strait, given the presence 
of a known vector, and suggests strategies to reduce 
the disease burden posed by malaria in this patient 
and other Torres Strait Islanders travelling to Papua 
New Guinea under the terms of the Torres Strait 
Treaty.  Commun Dis Intell 2010;34(4):448–449. 
 Case history
 A 57-year-old Torres Strait Islander male presented 
to the primary health centre on a remote island in 
the Torres Strait with a week-long history of fevers, 
myalgia and a cough productive of green sputum. 
He had recently returned from 3 weeks in Daru 
in Western Province, Papua New Guinea (PNG). 
The patient’s past medical history was significant in 
that he was HIV positive on antiretroviral therapy 
(lamivudine, zidovudine and azatanavir); though 
6 months earlier he had an undetectable viral load 
and a CD4 count of 0.5 x 10 9 /L indicating a reason-
able level of immune function. The previous year 
he had required hospital admission for severe com-
munity acquired pneumonia.
 On presentation he was hypoxic and in septic 
shock with rigors. He was also noted to have an 
infected ulcer on his left lower leg with associated 
left inguinal lymphadenopathy. An initial immuno-
chromatographic test for pan-malarial antigens was 
positive.
 The patient was transferred to Thursday Island 
Hospital where upon arrival he was commenced on 
artemether/lumefantrine combination therapy as 
well as intravenous ceftriaxone and gentamicin. A 
chest x-ray confirmed the diagnosis of pneumonia; 
malaria films on day two revealed  P. vivax  malaria 
with an initial parasite count of 23,000/μL and 
numerous trophozoites and occasional schizonts 
present. After excluding glucose-6-phosphate dehy-
drogenase deficiency, primaquine was commenced; 
artemether/lumefantrine was ceased after 6 doses 
as per the Torres Strait Malaria Protocol (S. Parish, 
2009 1 ). Blood and sputum cultures (including for 
acid-fast bacilli) were negative, as was serology for 
dengue and melioidosis. While an inpatient the 
patient’s white cell count reached a nadir of 3.2 (with 
a neutrophil count of 0.69) and platelets of 74. 
Repeat malaria parasite screens showed reduced 
trophozoite load by day two of admission and com-
plete clearance on days four and seven. The patient 
showed dramatic clinical improvement over the first 
few days of his admission and was discharged on day 
thirteen.
 Discussion
 While in many parts of the developing world the 
coexistence of HIV and malaria is unfortunately 
common, these infections are rarely seen together 
in Australia, where the burden of disease for each 
is relatively small. 2,3  The interaction between HIV 
infection and malaria has been extensively studied, 
with current knowledge suggesting that each infec-
tion may potentiate the other, mainly via effects on 
T-cell activation and immunity. More specifically, 
HIV has been shown to increase the infection rate, 
parasite density and severity of clinical illness of 
malaria, with an inversely proportional relationship 
between CD4 count and incidence of severe malaria, 
and decreases the response to malaria treatment. 4  
Conversely, malaria increases HIV viral load and 
transmission and contributes to the development of 
anaemia. 5  Research from sub-Saharan Africa indi-
cates that HIV-infected patients living in or travel-
ling to malarious areas benefit from chemoprophy-
laxis with cotrimoxazole, which has been shown 
to be effective in reducing the burden of disease 
due to malaria and HIV-associated opportunistic 
infections, although it should be noted that malaria 
infections in the African cohorts studied were due 
almost exclusively to  P. falciparum. 6  Another impor-
tant area of research concerns the chemotherapeutic 
interactions between drugs used for the treatment 
of HIV and malaria, with some antimalarial agents 
exerting a weak antiretroviral effect, and certain 
antiretrovirals demonstrating malarial parasite 
growth inhibition. 7 
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 In the Torres Strait, the number of cases of HIV 
is limited to a few individuals, and the majority of 
patients with malaria are from PNG, with a small 
number of cases in Torres Strait Islanders who 
acquire the disease in PNG. There have however 
been documented cases of locally-acquired malaria, 
including 2 cases of  P. vivax on Badu Island in 
1997 and one of  P. falciparum  on Darnley Island 
in 2001. 8,9  Australia has a potential malaria vector 
in the form of  Anopheles farauti sensu lato , which 
exists in the Torres Strait and represents the most 
significant threat with respect to local transmission 
of disease. During investigation of the Darnley case 
in 2001 several female  An. farauti s.l.  were trapped. 
In these previously reported cases the sources of 
the infections were unknown; none of the 3 indi-
viduals affected had travelled to PNG. The possible 
explanations for these cases include transport of an 
infected mosquito from PNG in one of the many 
boats that travel between PNG and the Torres Strait 
Islands (so-called ‘baggage malaria’), or travel to 
the Torres Strait by an asymptomatic PNG national 
with parasitaemia. In this case it is most likely that 
the patient acquired malaria in PNG, given the 
average incubation period for clinical  P. vivax  infec-
tion (12–17 days) and the patient’s travel history.
 Public health significance
 From a communicable disease perspective, this case 
is significant in several respects. Firstly, the concur-
rent infection with HIV and malaria in this patient 
incurred an increased risk of morbidity due to both 
diseases as discussed above. Secondly, the potential 
for local spread of  P. vivax  on the patient’s home 
island represented a small but significant risk to 
the local community, given the historical presence 
of a known vector on the island and the fact that 
the patient likely had an increased parasite load 
due to HIV infection. Thirdly, the particular liv-
ing arrangements of this patient, namely sharing a 
house with approximately 15 other individuals, lend 
themselves to vector-borne disease transmission. 
Finally, it is interesting that this patient almost cer-
tainly contracted both HIV and malaria on separate 
visits to PNG under the terms of the Torres Strait 
Treaty. This treaty allows free travel for traditional 
purposes, without passports or visas, within the 
Treaty zone for residents of the Torres Strait Islands 
and the inhabitants of 13 coastal village communi-
ties in PNG. 10  This unique arrangement represents 
a potential route for the spread of communicable 
diseases south to the Australian mainland. There 
exists a strong case for recommending routine use of 
malaria chemoprophylaxis for Torres Strait Islanders 
travelling to PNG, and additional cotrimoxazole 
prophylaxis for those with HIV infection. The 
efficacy of cotrimoxazole specifically for prophylaxis 
against  P. vivax  malaria warrants further investiga-
tion, given the relatively high prevalence of  P. vivax 
 malaria in PNG. 11 
 The patient gave verbal consent for publication of 
this case report.
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